Literature DB >> 25985059

Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging.

Ahmed Ba-Ssalamah1, Célia Antunes1, Diana Feier1, Nina Bastati1, Jacqueline C Hodge1, Judith Stift1, Maria A Cipriano1, Friedrich Wrba1, Michael Trauner1, Christian J Herold1, Filipe Caseiro-Alves1.   

Abstract

PURPOSE: To evaluate the diagnostic performance of imaging features of gadoxetic acid-enhanced magnetic resonance (MR) imaging to differentiate among hepatocellular adenoma (HCA) subtypes by using the histopathologic results of the new immunophenotype and genotype classification and to correlate the enhancement pattern on the hepatobiliary phase (HBP) with the degrees of expression of organic anion transporting polypeptide (OATP1B1/3), multidrug resistance-associated protein 2 (MRP) (MRP2), and MRP 3 (MRP3) transporters.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, and the requirement for informed consent waived. MR imaging findings of 29 patients with 43 HCAs were assessed by two radiologists independently then compared with the histopathologic analysis as the standard of reference. Receiver operating characteristic curves and Spearman rank correlation coefficient were used to test the diagnostic performance of gadoxetic acid-enhanced MR imaging features, which included the retention or washout at HBP and degree of transporter expression. Interreader agreement was assessed by using the κ statistic with 95% confidence interval.
RESULTS: The area under the curve for the diagnosis of inflammatory HCA was 0.79 (95% confidence interval: 0.64, 0.90); for the steatotic type, it was 0.90 (95% confidence interval: 0.77, 0.97); and for the β-catenin type, it was 0.87 (95% confidence interval: 0.74, 0.95). There were no imaging features that showed a significant statistical correlation for the diagnosis of unclassified HCAs. On immunohistochemical staining, OATP1B1/3 expression was the main determinant for the retention, whereas MRP3 was the key determinant for washout of gadoxetic acid at HBP (P < .001). MRP2 appeared to have no role.
CONCLUSION: Gadoxetic acid-enhanced MR imaging features may suggest the subtype of HCA. The degree of OATP1B1/3 and MRP3 expression correlated statistically with gadoxetic acid retention and washout, respectively, in the HBP. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985059     DOI: 10.1148/radiol.2015142366

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.

Authors:  Edouard Reizine; Maxime Ronot; Frederic Pigneur; Yvonne Purcell; Sebastien Mulé; Marco Dioguardi Burgio; Julien Calderaro; Giuliana Amaddeo; Alexis Laurent; Valérie Vilgrain; Alain Luciani
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 2.  Hepatocyte-specific contrast media: not so simple.

Authors:  Andrew T Trout; Alexander J Towbin; Ethan A Smith; Anita Gupta; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 3.  Lessons learnt from pathologic imaging correlation in the liver: an historical perspective.

Authors:  Yvonne Purcell; Pauline Copin; Valérie Paradis; Valérie Vilgrain; Maxime Ronot
Journal:  Br J Radiol       Date:  2019-01-10       Impact factor: 3.039

Review 4.  Magnetic resonance imaging of primary pediatric liver tumors.

Authors:  Brian S Pugmire; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2016-05-26

5.  Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.

Authors:  Ji Hye Min; Tae Wook Kang; Young Kon Kim; Seong Hyun Kim; Kyung Sook Shin; Jeong Eun Lee; Sang Yun Ha; Insuk Sohn
Journal:  Eur Radiol       Date:  2018-01-24       Impact factor: 5.315

Review 6.  Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors:  Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal:  Curr Gastroenterol Rep       Date:  2017-10-18

Review 7.  Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls.

Authors:  Mimi Tang; Yin Li; Zhi Lin; Bingqi Shen; Mengqi Huang; Zi-Ping Li; Xuehua Li; Shi-Ting Feng
Journal:  Abdom Radiol (NY)       Date:  2020-11

8.  Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.

Authors:  Edouard Reizine; Giuliana Amaddeo; Frederic Pigneur; Laurence Baranes; François Legou; Sebastien Mulé; Benhalima Zegai; Vincent Roche; Alexis Laurent; Alain Rahmouni; Julien Calderaro; Alain Luciani
Journal:  Eur Radiol       Date:  2018-05-02       Impact factor: 5.315

Review 9.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

10.  Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance.

Authors:  Kumi Ozaki; Kenichi Harada; Toru Yamamoto; Hiroyuki Aoyagi; Yasuharu Kaizaki; Jun Yoshikawa
Journal:  Clin J Gastroenterol       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.